Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jennifer Ken-Opurum, Girish Prajapati, Joana E. Matos, Swarnali Goswami & Princy Kumar. (2023) Body mass index and quality of life in people living with HIV. AIDS Care 35:10, pages 1542-1554.
Read now
Read now
Elvira Bangert, Laura Wakani, Mehveen Merchant, Vibeke Strand & Zahi Touma. (2019) Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies. Patient Related Outcome Measures 10, pages 1-7.
Read now
Read now
Jamal Mikdashi. (2018) Measuring and monitoring health-related quality of life responsiveness in systemic lupus erythematosus patients: current perspectives. Patient Related Outcome Measures 9, pages 339-343.
Read now
Read now
Michele Iudici, Rosaria Irace, Antonella Riccardi, Giovanna Cuomo, Serena Vettori & Gabriele Valentini. (2017) Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient Related Outcome Measures 8, pages 7-13.
Read now
Read now
Makio Furukawa, Chikako Kiyohara, Takahiko Horiuchi, Hiroshi Tsukamoto, Hiroki Mitoma, Yasutaka Kimoto, Ayumi Uchino, Misato Nakagawa, Kensuke Oryoji, Terufumi Shimoda & Koichi Akashi. (2016) Quality of life in Japanese female patients with systemic lupus erythematosus: Evaluation using the Short Form 36 Health Survey. Modern Rheumatology 26:2, pages 240-247.
Read now
Read now
Vibeke Strand & Alvina D Chu. (2011) Measuring outcomes in systemic lupus erythematosus clinical trials. Expert Review of Pharmacoeconomics & Outcomes Research 11:4, pages 455-468.
Read now
Read now
Dr Nicola Gullick & Dr David D’Cruz. (2007) New therapies for the treatment of systemic lupus erythematosus. Expert Opinion on Therapeutic Patents 17:3, pages 299-313.
Read now
Read now
Articles from other publishers (61)
Eric F Morand, Gabriel Abreu, Richard A Furie, Vera Golder & Raj Tummala. (2023) Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus. Annals of the Rheumatic Diseases 82:5, pages 639-645.
Crossref
Crossref
Yameng Yu & Lailiang Ou. (2023) The development of immunosorbents for the treatment of systemic lupus erythematosus via hemoperfusion. Frontiers in Medicine 9.
Crossref
Crossref
Sharzad Emamikia, Shereen Oon, Alvaro Gomez, Julius Lindblom, Alexander Borg, Yvonne Enman, Eric Morand, David Grannas, Ronald F van Vollenhoven, Mandana Nikpour & Ioannis Parodis. (2022) Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus. Rheumatology 61:12, pages 4752-4762.
Crossref
Crossref
Jennifer Pearson, Jessica Coggins, Sandi Derham, Julie Russell, Nicola E. Walsh, Erik Lenguerrand, Shea Palmer & Fiona Cramp. (2022) A feasibility randomised controlled trial of a Fibromyalgia Self-management Programme for adults in a community setting with a nested qualitative study (FALCON). BMC Musculoskeletal Disorders 23:1.
Crossref
Crossref
Ronald F van Vollenhoven, Kenneth C Kalunian, Thomas Dörner, Bevra H Hahn, Yoshiya Tanaka, Robert M Gordon, Cathye Shu, Kaiyin Fei, Sheng Gao, Loqmane Seridi, Patrick Gallagher, Kim Hung Lo, Pamela Berry & Qing C Zuraw. (2022) Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, pages annrheumdis-2022-222858.
Crossref
Crossref
Melody P Chung, Antonia Valenzuela, Shufeng Li, Benjamin Catanese, Kate Stevens, David Fiorentino, Vibeke Strand & Lorinda Chung. (2022) A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Rheumatology 61:6, pages 2441-2449.
Crossref
Crossref
Vibeke Strand, Sean O’Quinn, Richard A Furie, Eric F Morand, Kenneth C Kalunian, Erik G Schwetje, Gabriel Abreu & Raj Tummala. (2022) Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumab. The Lancet Rheumatology 4:3, pages e198-e207.
Crossref
Crossref
Alvaro Gomez, Victor Qiu, Arvid Cederlund, Alexander Borg, Julius Lindblom, Sharzad Emamikia, Yvonne Enman, Jon Lampa & Ioannis Parodis. (2021) Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus. Frontiers in Medicine 8.
Crossref
Crossref
Alvaro Gomez, Fawz Hani Butrus, Petter Johansson, Emil Åkerström, Sofia Soukka, Sharzad Emamikia, Yvonne Enman, Susanne Pettersson & Ioannis Parodis. (2021) Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus. Rheumatology 60:3, pages 1260-1272.
Crossref
Crossref
Prabjit Ajrawat, Vibeke Strand, Mark Matsos, Lee S. Simon & Zahi Touma. 2021. Outcome Measures and Metrics in Systemic Lupus Erythematosus. Outcome Measures and Metrics in Systemic Lupus Erythematosus
303
335
.
Zara Izadi. (2020) Health‐Related Quality of Life Measures in Adult Systemic Lupus Erythematosus. Arthritis Care & Research 72:S10, pages 577-592.
Crossref
Crossref
Alvaro Gomez, Sofia Soukka, Petter Johansson, Emil Åkerström, Sharzad Emamikia, Yvonne Enman, Katerina Chatzidionysiou & Ioannis Parodis. (2020) Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus. Journal of Clinical Medicine 9:6, pages 1813.
Crossref
Crossref
Vibeke Strand, Lee S Simon, Alexa Simon Meara & Zahi Touma. (2020) Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review. Lupus Science & Medicine 7:1, pages e000373.
Crossref
Crossref
M Jolly, N Annapureddy, L Arnaud & H Devilliers. (2019) Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial. Lupus 28:14, pages 1628-1639.
Crossref
Crossref
Vibeke Strand, Pamela Berry, Xiwu Lin, Yumi Asukai, Rajesh Punwaney & Sulabha Ramachandran. (2019) Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment. Arthritis Care & Research 71:6, pages 829-838.
Crossref
Crossref
Ioannis Parodis, Angie H. Lopez Benavides, Agneta Zickert, Susanne Pettersson, Sonia Möller, Elisabet Welin Henriksson, Anne Voss & Iva Gunnarsson. (2019) The Impact of Belimumab and Rituximab on Health‐Related Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research 71:6, pages 811-821.
Crossref
Crossref
Zahi Touma & Murray B. Urowitz. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes
598
605
.
Eckart Mummert, Marvin J. Fritzler, Christopher Sjöwall, Chelsea Bentow & Michael Mahler. (2018) The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination. Journal of Immunological Methods 459, pages 11-19.
Crossref
Crossref
Stephanie G. Nantes, Vibeke Strand, Jiandong Su & Zahi Touma. (2018) Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus. Arthritis Care & Research 70:1, pages 125-133.
Crossref
Crossref
Andrew Kwan, Vibeke Strand & Zahi Touma. (2017) The Role of Patient-Reported Outcomes in Systemic Lupus Erythematosus. Current Treatment Options in Rheumatology 3:4, pages 308-321.
Crossref
Crossref
Daniel J Wallace, Vibeke Strand, Joan T Merrill, Serghei Popa, Alberto J Spindler, Alicia Eimon, Michelle Petri, Josef S Smolen, Joseph Wajdula, Jared Christensen, Cheryl Li, Annette Diehl, Michael S Vincent, Jean Beebe, Paul Healey & Sudhakar Sridharan. (2017) Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial. Annals of the Rheumatic Diseases 76:3, pages 534-542.
Crossref
Crossref
Kathleen McElhone, Janice Abbott, Chris Sutton, Montana Mullen, Peter Lanyon, Anisur Rahman, Chee‐Seng Yee, Mohammed Akil, Ian N. Bruce, Yasmeen Ahmad, Caroline Gordon & Lee‐Suan Teh. (2016) Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research 68:10, pages 1505-1513.
Crossref
Crossref
N Annapureddy, H Devilliers & M Jolly. (2016) Patient-reported outcomes in lupus clinical trials with biologics. Lupus 25:10, pages 1111-1121.
Crossref
Crossref
Sibel Yilmaz-Oner, Can Oner, Fatih Mert Dogukan, Toklong Filam Moses, Kubra Demir, Nazar Tekayev, Pamir Atagunduz, Serhan Tuglular & Haner Direskeneli. (2015) Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus. Clinical Rheumatology 35:3, pages 617-622.
Crossref
Crossref
Sharan K Rai, Jinoos Yazdany, Paul R Fortin & J Antonio Aviña-Zubieta. (2015) Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Research & Therapy 17:1.
Crossref
Crossref
John G. Hanly, Li Su, Murray B. Urowitz, Juanita Romero‐Diaz, Caroline Gordon, Sang‐Cheol Bae, Sasha Bernatsky, Ann E. Clarke, Daniel J. Wallace, Joan T. Merrill, David A. Isenberg, Anisur Rahman, Ellen M. Ginzler, Michelle Petri, Ian N. Bruce, M. A. Dooley, Paul Fortin, Dafna D. Gladman, Jorge Sanchez‐Guerrero, Kristjan Steinsson, Rosalind Ramsey‐Goldman, Munther A. Khamashta, Cynthia Aranow, Graciela S. Alarcón, Barri J. Fessler, Susan Manzi, Ola Nived, Gunnar K. Sturfelt, Asad A. Zoma, Ronald F. van Vollenhoven, Manuel Ramos‐Casals, Guillermo Ruiz‐Irastorza, S. Sam Lim, Kenneth C. Kalunian, Murat Inanc, Diane L. Kamen, Christine A. Peschken, Soren Jacobsen, Anca Askanase, Chris Theriault, Kara Thompson & Vernon Farewell. (2015) Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis & Rheumatology 67:7, pages 1837-1847.
Crossref
Crossref
Jasvinder A Singh, Shahrzad Noorbaloochi, Carter Thorne, Glen S Hazlewood, Maria E Suarez-Almazor, Elizabeth Tanjong Ghogomu, George A Wells & Peter Tugwell. (2015) Subcutaneous or intramuscular methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Vibeke Strand & Alvina D. Chu. 2015. Rheumatology. Rheumatology
1093
1098
.
M. Urowitz, D. D. Gladman, D. Ibañez, J. Sanchez-Guerrero, S. C. Bae, C. Gordon, P. R. Fortin, A. Clarke, S. Bernatsky, J. G. Hanly, D. J. Wallace, D. Isenberg, A. Rahman, J. Merrill, E. Ginzler, G. S. Alarcón, B. Fessler, M. Khamashta, K. Steinsson, M. Petri, M. Dooley, I. N. Bruce, S. Manzi, G. Sturfelt, O. Nived, R. Ramsey-Goldman, A. Zoma, P. Maddison, K. Kalunian, R. van Vollenhoven, C. Aranow, J. Romero Diaz & T. Stoll. (2014) Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus. Arthritis Care & Research 66:9, pages 1374-1379.
Crossref
Crossref
Richard Furie, Michelle A Petri, Vibeke Strand, Dafna D Gladman, Z John Zhong & William W Freimuth. (2014) Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials. Lupus Science & Medicine 1:1, pages e000031.
Crossref
Crossref
George Wells, Dorcas E. Beaton, Peter Tugwell, Maarten Boers, John R. Kirwan, Clifton O. BinghamIIIIII, Annelies Boonen, Peter Brooks, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Laure Gossec, Francis Guillemin, Philip Helliwell, Sarah Hewlett, Tore K. Kvien, Robert B. Landewé, Lyn March, Philip J. Mease, Mikkel Ostergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand & Désirée M. van der Heijde. (2014) Updating the OMERACT Filter: Discrimination and Feasibility. The Journal of Rheumatology 41:5, pages 1005-1010.
Crossref
Crossref
Vibeke Strand, Roger A Levy, Ricard Cervera, Michelle A Petri, Helen Birch, William W Freimuth, Z John Zhong & Ann E Clarke. (2014) Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials. Annals of the Rheumatic Diseases 73:5, pages 838-844.
Crossref
Crossref
V. Strand, M. Petri, K. Kalunian, C. Gordon, D. J. Wallace, K. Hobbs, L. Kelley, B. Kilgallen, W. A. Wegener & D. M. Goldenberg. (2013) Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006. Rheumatology 53:3, pages 502-511.
Crossref
Crossref
C. Gordon, D. Isenberg, K. Lerstrom, Y. Norton, E. Nikai, D. S. Pushparajah & M. Schneider. (2013) The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey. Rheumatology 52:12, pages 2292-2301.
Crossref
Crossref
Michelle Petri, Ariane K. Kawata, Ancilla W. Fernandes, Kavita Gajria, Warren Greth, Asha Hareendran & Dominique Ethgen. (2013) Impaired Health Status and the Effect of Pain and Fatigue on Functioning in Clinical Trial Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology 40:11, pages 1865-1874.
Crossref
Crossref
John G. Hanly, Murray B. Urowitz, Aidan G. O'Keeffe, Caroline Gordon, Sang‐Cheol Bae, Jorge Sanchez‐Guerrero, Juanita Romero‐Diaz, Ann E. Clarke, Sasha Bernatsky, Daniel J. Wallace, Ellen M. Ginzler, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Michelle Petri, Paul R. Fortin, Dafna D. Gladman, Barri J. Fessler, Graciela S. Alarcón, Ian N. Bruce, Mary Anne Dooley, Kristjan Steinsson, Munther A. Khamashta, Rosalind Ramsey‐Goldman, Susan Manzi, Gunnar K. Sturfelt, Ola Nived, Asad A. Zoma, Ronald F. van Vollenhoven, Manuel Ramos‐Casals, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz‐Irastorza, Kenneth C. Kalunian, S. Sam Lim, Murat Inanc, Diane L. Kamen, Christine A. Peschken, Soren Jacobsen, Chris Theriault, Kara Thompson & Vernon Farewell. (2013) Headache in Systemic Lupus Erythematosus: Results From a Prospective, International Inception Cohort Study. Arthritis & Rheumatism 65:11, pages 2887-2897.
Crossref
Crossref
A. N. Kiani, V. Strand, H. Fang, J. Jaranilla & M. Petri. (2013) Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology 52:9, pages 1651-1657.
Crossref
Crossref
V Strand, C Galateanu, DS Pushparajah, E Nikaï, J Sayers, R Wood & RF van Vollenhoven. (2013) Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey. Lupus 22:8, pages 819-826.
Crossref
Crossref
A. Schmeding & M. Schneider. (2013) Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 27:3, pages 363-375.
Crossref
Crossref
N Kasitanon, S Wangkaew, S Puntana, W Sukitawut, KP Leong & W Louthrenoo. (2013) The reliability, validity and responsiveness of the Thai version of systemic lupus erythematosus quality of life (SLEQOL-TH) instrument. Lupus 22:3, pages 289-296.
Crossref
Crossref
VIBEKE STRAND, DINESH KHANNA, JASVINDER A. SINGH, ANNA FORSYTHE & N. LAWRENCE EDWARDS. (2012) Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials. The Journal of Rheumatology 39:7, pages 1450-1457.
Crossref
Crossref
VIBEKE STRAND & ALVINA D. CHU. (2011) Generic Versus Disease-specific Measures of Health-related Quality of Life in Systemic Lupus Erythematosus. The Journal of Rheumatology 38:9, pages 1821-1823.
Crossref
Crossref
ZAHI TOUMA, DAFNA D. GLADMAN, DOMINIQUE IBAÑEZ & MURRAY B. UROWITZ. (2011) Is There an Advantage Over SF-36 with a Quality of Life Measure That Is Specific to Systemic Lupus Erythematosus?. The Journal of Rheumatology 38:9, pages 1898-1905.
Crossref
Crossref
CLIFTON O. BINGHAMIIIIII, RIEKE ALTEN, SUSAN J. BARTLETT, VIVIAN P. BYKERK, PETER M. BROOKS, ERNEST CHOY, ROBIN CHRISTENSEN, DANIEL E. FURST, SARAH E. HEWLETT, AMYE LEONG, JAMES E. MAY, PAM MONTIE, CHRISTOF POHL, TESSA C. SANDERSON, VIBEKE STRAND & THASIA G. WOODWORTH. (2011) Identifying Preliminary Domains to Detect and Measure Rheumatoid Arthritis Flares: Report of the OMERACT 10 RA Flare Workshop. The Journal of Rheumatology 38:8, pages 1751-1758.
Crossref
Crossref
VIBEKE STRAND, MAARTEN BOERS, LEANNE IDZERDA, JOHN R. KIRWAN, TORE K. KVIEN, PETER S. TUGWELL & MAXIME DOUGADOS. (2011) It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.. The Journal of Rheumatology 38:8, pages 1720-1727.
Crossref
Crossref
J. ThumbooK-Y. Fong. (2010) Health-related quality of life of patients with systemic lupus erythematosus in Asia: how can this be improved?. Lupus 19:12, pages 1430-1435.
Crossref
Crossref
Jinoos Yazdany & Edward Yelin. (2010) Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 36:1, pages 15-32.
Crossref
Crossref
Vibeke Strand & Jasvinder A. Singh. (2010) Newer Biological Agents in Rheumatoid Arthritis. Drugs 70:2, pages 121-145.
Crossref
Crossref
CLIFTON O. BINGHAMIIIIII, CHRISTOPH POHL, THASIA G. WOODWORTH, SARAH E. HEWLETT, JAMES E. MAY, MAHBOOB U. RAHMAN, JAMES P. WITTER, DANIEL E. FURST, C. VIBEKE STRAND, MAARTEN BOERS & RIEKE E. ALTEN. (2009) Developing a Standardized Definition for Disease “Flare” in Rheumatoid Arthritis (OMERACT 9 Special Interest Group): Table 1.. The Journal of Rheumatology 36:10, pages 2335-2341.
Crossref
Crossref
Daniel J. Wallace, William Stohl, Richard A. Furie, Jeffrey R. Lisse, James D. McKay, Joan T. Merrill, Michelle A. Petri, Ellen M. Ginzler, W. Winn Chatham, W. Joseph McCune, Vivian Fernandez, Marc R. Chevrier, Z. John Zhong & William W. Freimuth. (2009) A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Care & Research 61:9, pages 1168-1178.
Crossref
Crossref
Richard A. Furie, Michelle A. Petri, Daniel J. Wallace, Ellen M. Ginzler, Joan T. Merrill, William Stohl, W. Winn Chatham, Vibeke Strand, Arthur Weinstein, Marc R. Chevrier, Z. John Zhong & William W. Freimuth. (2009) Novel evidence‐based systemic lupus erythematosus responder index. Arthritis Care & Research 61:9, pages 1143-1151.
Crossref
Crossref
Jasvinder A. Singh. (2009) Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty. Clinical Rheumatology 28:9, pages 1083-1089.
Crossref
Crossref
JASVINDER A. SINGH & VIBEKE STRAND. (2009) Spondyloarthritis Is Associated with Poor Function and Physical Health-Related Quality of Life. The Journal of Rheumatology 36:5, pages 1012-1020.
Crossref
Crossref
JANET E. POPE, DINESH KHANNA, DEBORAH NORRIE & JANINE M. OUIMET. (2009) The Minimally Important Difference for the Health Assessment Questionnaire in Rheumatoid Arthritis Clinical Practice Is Smaller Than in Randomized Controlled Trials. The Journal of Rheumatology 36:2, pages 254-259.
Crossref
Crossref
Vibeke Strand & Jasvinder A. Singh. 2009. Rheumatoid Arthritis. Rheumatoid Arthritis
237
259
.
J. A. Singh & J. A. Sloan. (2008) Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty. Rheumatology 47:12, pages 1826-1831.
Crossref
Crossref
Mario H. Cardiel, James A. Tumlin, Richard A. Furie, Daniel J. Wallace, Tenshang Joh & Matthew D. Linnik. (2008) Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial. Arthritis & Rheumatism 58:8, pages 2470-2480.
Crossref
Crossref
Vibeke Strand. (2007) A novel means to demonstrate early efficacy of a product in systemic lupus erythematosus. Current Rheumatology Reports 9:6, pages 427-430.
Crossref
Crossref
Dinesh Khanna, Xiaohong Yan, Donald P. Tashkin, Daniel E. Furst, Robert Elashoff, Michael D. Roth, Richard Silver, Charlie Strange, Marcy Bolster, James R. Seibold, David J. Riley, Vivien M. Hsu, John Varga, Dean E. Schraufnagel, Arthur Theodore, Robert Simms, Robert Wise, Fredrick Wigley, Barbara White, Virginia Steen, Charles Read, Maureen Mayes, Ed Parsley, Kamal Mubarak, M. Kari Connolly, Jeffrey Golden, Mitchell Olman, Barri Fessler, Naomi Rothfield, Mark Metersky & Philip J. Clements. (2007) Impact of oral cyclophosphamide on health‐related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study. Arthritis & Rheumatism 56:5, pages 1676-1684.
Crossref
Crossref
Vibeke Strand. (2007) Lessons learned from clinical trials in SLE. Autoimmunity Reviews 6:4, pages 209-214.
Crossref
Crossref
Julian Thumboo & Vibeke Strand. (2007) Health-related Quality of Life in Patients with Systemic Lupus Erythematosus: An Update. Annals of the Academy of Medicine, Singapore 36:2, pages 115-122.
Crossref
Crossref